CareTrust REIT (CTRE) Financials

$28.59 +0.27 (+0.96%)

Closing price 05/23/2025 03:59 PM Eastern

Extended Trading

$28.60 +0.01 (+0.03%)

As of 05/23/2025 07:45 PM Eastern

Annual Income Statements for CareTrust REIT

This table shows CareTrust REIT's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	125	54	-7.51	72	81	46	58	26	29	10
Consolidated Net Income / (Loss)	124	54	-7.51	72	81	46	58	26	29	10
Net Income / (Loss) Continuing Operations	124	54	-7.51	72	81	46	58	26	29	10
Total Pre-Tax Income	124	54	-7.51	72	81	46	58	26	29	10
Total Operating Income	82	80	25	107	105	73	84	47	52	33
Total Gross Profit	224	195	182	192	176	161	154	130	102	74
Total Revenue	229	199	188	192	178	163	157	133	105	74
Operating Revenue	229	199	188	192	178	163	157	133	105	74
Total Cost of Revenue	5.71	3.42	5.04	0.00	1.87	2.90	2.96	2.73	2.55	0.00
Operating Cost of Revenue	5.71	3.42	5.04	0.00	1.87	2.90	2.96	2.73	2.55	-
Total Operating Expenses	142	115	158	86	72	88	70	84	50	41
Selling, General & Admin Expense	29	22	20	27	16	15	13	11	9.30	7.66
Depreciation Expense	57	51	50	55	53	52	46	39	32	24
Other Operating Expenses / (Income)	14	6.17	8.18	3.57	2.84	4.12	12	33	8.17	9.08
Impairment Charge	42	36	79	0.00	0.00	17	0.00	0.89	0.00	0.00
Total Other Income / (Expense), net	43	-26	-32	-35	-24	-26	-26	-21	-23	-23
Interest Expense	31	41	30	35	24	28	28	24	23	24
Interest & Investment Income	67	19	8.63	-	-	-	-	3.54	0.00	0.97
Other Income / (Expense), net	6.84	-4.27	-11	-0.08	-0.04	1.78	2.05	0.00	-0.27	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.68	-0.01	0.00	0.00	-	-	-	-	-	-
Basic Earnings per Share	$0.81	$0.50	($0.08)	$0.74	$0.85	$0.49	$0.73	$0.35	$0.52	$0.26
Weighted Average Basic Shares Outstanding	154.80M	105.96M	96.70M	96.02M	95.20M	93.09M	79.39M	72.65M	56.03M	37.38M
Diluted Earnings per Share	$0.80	$0.50	($0.08)	$0.74	$0.85	$0.49	$0.72	$0.35	$0.52	$0.26
Weighted Average Diluted Shares Outstanding	155.17M	106.15M	96.70M	96.09M	95.21M	93.10M	79.39M	72.65M	56.03M	37.38M
Weighted Average Basic & Diluted Shares Outstanding	187.66M	130.50M	99.51M	97.05M	95.89M	95.47M	88.85M	76.14M	66.22M	48.15M
Cash Dividends to Common per Share	$1.16	$1.12	$1.10	$1.06	$1.00	$0.90	$0.82	$0.74	$0.68	$0.64

This table shows CareTrust REIT's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	66	52	33	11	29	26	8.70	-0.48	19	14	0.71
Consolidated Net Income / (Loss)	65	52	33	10	29	26	8.69	-0.48	19	14	0.71
Net Income / (Loss) Continuing Operations	66	52	33	10	29	26	8.69	-0.48	19	14	0.71
Total Pre-Tax Income	66	52	33	10	29	26	8.69	-0.48	19	14	0.71
Total Operating Income	45	-20	43	21	38	14	26	11	30	19	16
Total Gross Profit	74	19	74	69	62	40	55	51	50	42	46
Total Revenue	74	20	77	69	63	41	56	52	51	43	50
Operating Revenue	74	20	77	69	63	41	56	52	51	43	50
Total Cost of Revenue	0.11	1.32	3.48	0.26	0.66	0.56	1.24	0.66	0.96	0.70	3.81
Operating Cost of Revenue	0.11	1.32	3.48	0.26	0.66	0.56	1.24	0.66	0.96	0.70	3.81
Total Operating Expenses	29	38	31	48	25	26	29	40	20	23	30
Selling, General & Admin Expense	9.02	9.29	6.66	6.14	6.84	6.51	5.52	4.72	5.06	4.81	5.16
Depreciation Expense	18	16	14	14	13	13	13	13	12	12	12
Other Operating Expenses / (Income)	2.07	8.17	2.12	1.98	1.80	1.73	2.17	1.39	0.88	0.97	0.69
Impairment Charge	0.00	5.35	8.42	26	2.74	4.79	8.23	21	1.89	5.36	12
Total Other Income / (Expense), net	21	72	-9.42	-11	-8.83	13	-17	-11	-10	-5.05	-15
Interest Expense	6.67	5.12	8.94	8.68	8.23	8.27	12	11	9.83	9.61	8.36
Interest & Investment Income	22	-	-	-	-	-	-	-	-	-	-
Other Income / (Expense), net	5.16	9.78	-0.49	-1.86	-0.60	1.63	-5.25	-0.12	-0.52	-4.06	-6.99
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.61	-0.18	-0.17	-0.34	0.00	-0.00	-0.01	0.00	0.00	-	0.00
Basic Earnings per Share	$0.35	$0.31	$0.21	$0.07	$0.22	$0.24	$0.08	($0.01)	$0.19	$0.15	$0.01
Weighted Average Basic Shares Outstanding	187.15M	154.80M	159.46M	144.90M	132.84M	105.96M	104.01M	99.12M	99.06M	96.70M	96.61M
Diluted Earnings per Share	$0.35	$0.30	$0.21	$0.07	$0.22	$0.24	$0.08	($0.01)	$0.19	$0.15	$0.01
Weighted Average Diluted Shares Outstanding	187.42M	155.17M	159.85M	145.26M	133.20M	106.15M	104.31M	99.12M	99.09M	96.70M	96.63M
Weighted Average Basic & Diluted Shares Outstanding	191.69M	187.66M	171.45M	154.21M	142.06M	130.50M	119.11M	99.48M	99.48M	99.51M	97.03M
Cash Dividends to Common per Share	$0.34	-	$0.29	$0.29	$0.29	-	$0.28	$0.28	$0.28	-	$0.28

This table details how cash moves in and out of CareTrust REIT's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-81	281	-6.72	0.98	-1.41	-16	30	-0.59	-3.97	-14
Net Cash From Operating Activities	244	155	144	157	146	126	99	89	64	40
Net Cash From Continuing Operating Activities	244	155	144	157	146	126	99	89	64	40
Net Income / (Loss) Continuing Operations	124	54	-7.51	72	81	46	58	26	29	10
Consolidated Net Income / (Loss)	124	54	-7.51	72	81	46	58	26	29	10
Depreciation Expense	57	51	50	55	53	52	46	39	32	24
Amortization Expense	-0.05	2.05	2.10	2.05	1.95	2.00	1.94	2.10	2.24	2.20
Non-Cash Adjustments To Reconcile Net Income	43	45	100	22	5.10	30	-0.77	26	1.25	1.79
Changes in Operating Assets and Liabilities, net	20	2.39	-0.32	5.89	5.00	-4.08	-5.51	-4.42	-0.39	2.10
Net Cash From Investing Activities	-1,514	-268	-127	-193	-42	-316	-115	-303	-285	-235
Net Cash From Continuing Investing Activities	-1,514	-268	-127	-193	-42	-316	-115	-303	-285	-235
Purchase of Property, Plant & Equipment	-8.05	-11	-7.29	-6.01	-8.30	-6.29	-9.01	-0.40	-281	-233
Acquisitions	-57	-239	0.00	0.00	-3.00	-321	-117	-297	-5.36	-1.75
Purchase of Investments	-655	-60	-150	-1.25	-30	-	-	-	0.00	0.00
Sale of Property, Plant & Equipment	14	16	45	6.96	6.61	3.50	13	0.00	2.86	-
Other Investing Activities, net	-807	27	-16	-192	-8.72	6.04	-2.42	-13	-0.76	-0.19
Net Cash From Financing Activities	1,189	394	-24	37	-106	173	46	213	216	181
Net Cash From Continuing Financing Activities	1,189	394	-24	37	-106	173	46	213	216	181
Repayment of Debt	-284	-310	-120	-504	-75	-383	-135	-442	-301	-40
Payment of Dividends	-172	-116	-106	-101	-93	-81	-63	-53	-37	-22
Issuance of Debt	75	185	160	620	65	443	65	538	355	80
Issuance of Common Equity	1,573	636	47	23	-0.40	196	180	170	200	163
Other Financing Activities, net	-2.48	-1.48	-4.47	-1.33	-2.00	-2.52	-1.29	-0.87	-0.52	-0.15
Cash Interest Paid	28	40	26	23	22	26	26	30	21	22

This table details how cash moves in and out of CareTrust REIT's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	419	-163	-118	44	157	291	2.34	-27	15	8.32	-25
Net Cash From Operating Activities	71	75	67	53	49	43	45	32	35	34	42
Net Cash From Continuing Operating Activities	71	75	67	53	49	43	45	32	35	34	42
Net Income / (Loss) Continuing Operations	65	52	33	10	29	26	8.69	-0.48	19	14	0.71
Consolidated Net Income / (Loss)	65	52	33	10	29	26	8.69	-0.48	19	14	0.71
Depreciation Expense	18	16	14	14	13	13	13	13	12	12	12
Amortization Expense	0.04	0.06	-1.34	1.19	0.04	0.23	0.61	0.61	0.61	0.54	0.52
Non-Cash Adjustments To Reconcile Net Income	-3.15	2.76	9.20	26	5.05	4.66	15	22	3.50	11	20
Changes in Operating Assets and Liabilities, net	-8.56	4.87	12	1.05	1.52	-1.74	8.07	-3.47	-0.47	-4.33	9.23
Net Cash From Investing Activities	-36	-686	-359	-345	-123	-36	-56	-176	-0.82	14	-16
Net Cash From Continuing Investing Activities	-36	-686	-359	-345	-123	-36	-56	-176	-0.82	14	-16
Purchase of Property, Plant & Equipment	-2.28	-3.86	-2.87	-0.93	-0.40	-1.84	-2.76	-4.36	-2.02	-1.82	-1.85
Acquisitions	-36	-0.39	166	-219	-4.11	-37	-202	17	-17	22	-22
Purchase of Investments	-6.39	-150	-260	-193	-52	-9.63	-23	-27	0.00	-	-48
Sale of Property, Plant & Equipment	44	8.86	4.94	0.09	0.05	1.85	-	11	3.23	11	33
Other Investing Activities, net	-36	-540	-267	67	-67	11	173	-172	15	-17	22
Net Cash From Financing Activities	383	447	174	336	231	284	13	117	-19	-40	-52
Net Cash From Continuing Financing Activities	383	447	174	336	231	284	13	117	-19	-40	-52
Repayment of Debt	-0.14	-8.79	-275	-	-0.02	-0.05	-310	-	-0.02	-75	-45
Payment of Dividends	-55	-50	-45	-41	-37	-32	-28	-28	-27	-27	-27
Issuance of Debt	425	-	-	75	0.00	-	30	145	10	15	20
Issuance of Common Equity	17	506	494	303	270	316	321	-0.13	-0.50	47	-
Other Financing Activities, net	-3.33	-0.00	-	-	-2.48	-	-	-	-1.48	-	-
Cash Interest Paid	0.45	8.01	4.63	12	3.77	11	7.54	14	6.67	11	3.91

This table presents CareTrust REIT's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	3,437	2,085	1,621	1,641	1,504	1,519	1,292	1,185	925	673
Total Current Assets	347	318	25	30	31	34	57	13	15	16
Cash & Equivalents	214	294	13	20	19	20	37	6.91	7.50	11
Note & Lease Receivable	96	0.00	-	-	-	-	-	-	-	-
Accounts Receivable	1.17	0.40	0.42	2.42	1.82	2.57	11	5.25	5.90	2.34
Prepaid Expenses	36	23	12	7.51	10	11	8.67	0.90	1.37	2.08
Plant, Property, & Equipment, net	2,227	1,567	1,421	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	864	200	174	1,611	1,472	1,485	1,235	1,172	911	657
Long-Term Investments	795	180	156	15	15	33	18	18	14	8.48
Other Noncurrent Operating Assets	68	19	18	1,596	1,457	1,452	1,217	1,154	897	649
Total Liabilities & Shareholders' Equity	3,437	2,085	1,621	1,641	1,504	1,519	1,292	1,185	925	673
Total Liabilities	508	666	771	725	589	591	524	590	473	411
Total Current Liabilities	111	71	52	25	20	15	34	31	23	17
Accounts Payable	56	34	24	25	20	15	16	17	12	9.27
Dividends Payable	54	37	28	-	-	-	18	14	11	7.70
Total Noncurrent Liabilities	397	596	719	700	570	576	490	559	450	394
Long-Term Debt	397	596	719	673	546	555	490	559	450	394
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	18	0.00	-	-	-	-	-	-	-	-
Total Equity & Noncontrolling Interests	2,911	1,419	849	916	914	928	768	595	452	262
Total Preferred & Common Equity	2,908	1,417	849	916	914	928	768	595	452	262
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,908	1,417	849	916	914	928	768	595	452	262
Common Stock	3,441	1,884	1,246	1,198	1,165	1,164	966	784	612	411
Other Equity Adjustments	-533	-468	-397	-282	-251	-236	-198	-189	-160	-148
Noncontrolling Interest	2.72	1.90	0.00	-	-	-	-	-	-	-

This table presents CareTrust REIT's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	3,884	2,921	2,699	2,348	1,768	1,737	1,622	1,646
Total Current Assets	199	412	527	479	25	16	58	25
Cash & Equivalents	27	377	495	451	3.49	1.15	28	4.86
Note & Lease Receivable	97	-	-	-	-	-	-	-
Accounts Receivable	1.95	0.88	1.10	0.40	0.38	0.39	0.44	0.81
Prepaid Expenses	74	34	31	28	21	14	30	19
Plant, Property, & Equipment, net	2,252	1,749	1,706	1,619	1,536	1,528	0.00	1,384
Total Noncurrent Assets	1,433	760	466	250	207	193	1,564	237
Long-Term Investments	800	741	434	233	181	167	141	159
Other Noncurrent Operating Assets	633	19	32	16	26	26	1,423	78
Total Liabilities & Shareholders' Equity	3,884	2,921	2,699	2,348	1,768	1,737	1,622	1,646
Total Liabilities	936	496	753	672	657	924	782	832
Total Current Liabilities	114	99	82	76	61	329	24	58
Accounts Payable	51	50	37	35	29	21	24	31
Dividends Payable	63	50	45	41	32	28	-	27
Total Noncurrent Liabilities	822	397	671	596	595	595	758	774
Long-Term Debt	822	397	671	596	595	595	730	774
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	17	-	-	-	-	-	-	-
Total Equity & Noncontrolling Interests	2,931	2,425	1,946	1,676	1,111	813	840	814
Total Preferred & Common Equity	2,927	2,422	1,944	1,674	1,110	813	840	814
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,927	2,422	1,944	1,674	1,110	813	840	813
Common Stock	3,457	2,953	2,458	2,154	1,567	1,247	1,246	1,197
Other Equity Adjustments	-530	-530	-514	-480	-457	-434	-405	-384
Noncontrolling Interest	3.47	2.54	2.08	2.30	1.06	-	-	-

This table displays calculated financial ratios and metrics derived from CareTrust REIT's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	15.44%	5.92%	-2.52%	7.86%	9.14%	4.12%	18.02%	27.04%	41.48%	25.62%
EBITDA Growth	12.81%	94.04%	-59.53%	2.91%	24.11%	-3.86%	52.04%	1.58%	45.41%	261.18%
EBIT Growth	17.12%	443.63%	-86.97%	1.87%	40.34%	-13.17%	84.35%	-10.90%	57.70%	506.69%
NOPAT Growth	2.27%	360.09%	-83.74%	1.91%	43.82%	-13.17%	79.95%	-11.35%	58.50%	680.99%
Net Income Growth	131.56%	815.72%	-110.43%	-10.99%	74.44%	-19.96%	123.87%	-11.85%	192.54%	223.22%
EPS Growth	60.00%	725.00%	-110.81%	-12.94%	73.47%	-31.94%	105.71%	-32.69%	100.00%	172.22%
Operating Cash Flow Growth	57.82%	7.17%	-7.94%	7.64%	15.39%	27.11%	11.89%	37.82%	60.06%	83.76%
Free Cash Flow Firm Growth	-928.21%	-148.05%	765.38%	-120.24%	179.55%	-2,558.06%	102.69%	-4.57%	-11.34%	-780.70%
Invested Capital Growth	50.48%	10.45%	-8.19%	9.00%	-0.19%	17.01%	6.85%	28.13%	38.50%	47.92%
Revenue Q/Q Growth	-14.79%	-5.36%	-3.63%	3.28%	-0.05%	-17.68%	37.23%	6.55%	7.07%	8.17%
EBITDA Q/Q Growth	-22.57%	-5.59%	-14.45%	-0.83%	-0.46%	-19.99%	66.77%	-10.23%	-6.66%	96.38%
EBIT Q/Q Growth	-33.50%	-10.23%	-39.59%	-2.01%	-0.90%	-31.09%	161.01%	-21.05%	-12.81%	490.43%
NOPAT Q/Q Growth	-39.24%	-15.21%	-16.57%	-2.09%	0.57%	-32.60%	171.72%	-21.05%	-12.37%	490.43%
Net Income Q/Q Growth	25.99%	28.50%	-107.06%	-3.74%	0.49%	12.42%	29.77%	-19.17%	13.04%	77.19%
EPS Q/Q Growth	8.11%	21.95%	-100.00%	-3.90%	1.19%	6.52%	28.57%	-27.08%	8.33%	36.84%
Operating Cash Flow Q/Q Growth	15.37%	6.12%	-3.19%	0.74%	4.45%	3.41%	5.41%	8.49%	6.09%	19.84%
Free Cash Flow Firm Q/Q Growth	-996.65%	-684.70%	13.42%	61.73%	-20.52%	-5.84%	107.98%	9.15%	-112.25%	0.00%
Invested Capital Q/Q Growth	35.27%	1.41%	-1.68%	-0.24%	2.41%	0.37%	2.77%	4.98%	10.84%	-1.33%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	97.51%	98.28%	97.31%	100.00%	98.95%	98.23%	98.11%	97.94%	97.56%	100.00%
EBITDA Margin	63.35%	64.83%	35.39%	85.23%	89.33%	78.55%	85.07%	66.03%	82.58%	80.35%
Operating Margin	35.55%	40.13%	13.20%	55.40%	58.64%	44.50%	53.35%	34.99%	50.14%	44.76%
EBIT Margin	38.54%	37.98%	7.40%	55.36%	58.61%	45.58%	54.66%	34.99%	49.89%	44.76%
Profit (Net Income) Margin	54.26%	27.05%	-4.00%	37.42%	45.35%	28.37%	36.91%	19.46%	28.04%	13.56%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	140.80%	71.22%	-54.09%	67.60%	77.36%	62.24%	67.52%	55.60%	56.20%	30.30%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	4.13%	5.31%	1.16%	7.15%	7.33%	5.49%	7.08%	4.57%	6.84%	6.14%
ROIC Less NNEP Spread (ROIC-NNEP)	-17.29%	-1.76%	-2.92%	1.14%	2.65%	-0.04%	1.93%	0.39%	1.20%	-0.43%
Return on Net Nonoperating Assets (RNNOA)	1.59%	-0.57%	-2.01%	0.72%	1.46%	-0.02%	1.42%	0.37%	1.38%	-0.80%
Return on Equity (ROE)	5.72%	4.74%	-0.85%	7.87%	8.78%	5.47%	8.50%	4.94%	8.21%	5.34%
Cash Return on Invested Capital (CROIC)	-36.18%	-4.63%	9.70%	-1.46%	7.52%	-10.18%	0.46%	-20.09%	-25.45%	-32.52%
Operating Return on Assets (OROA)	3.20%	4.07%	0.85%	6.77%	6.92%	5.30%	6.93%	4.41%	6.53%	5.77%
Return on Assets (ROA)	4.51%	2.90%	-0.46%	4.58%	5.35%	3.30%	4.68%	2.45%	3.67%	1.75%
Return on Common Equity (ROCE)	5.69%	4.73%	-0.85%	7.87%	8.78%	5.47%	8.50%	4.94%	8.21%	5.34%
Return on Equity Simple (ROE_SIMPLE)	4.28%	3.79%	-0.88%	7.86%	8.85%	5.00%	7.54%	4.35%	6.49%	3.83%
Net Operating Profit after Tax (NOPAT)	82	80	17	107	105	73	84	47	52	33
NOPAT Margin	35.55%	40.13%	9.24%	55.40%	58.64%	44.50%	53.35%	34.99%	50.14%	44.76%
Net Nonoperating Expense Percent (NNEP)	21.42%	7.07%	4.08%	6.01%	4.68%	5.53%	5.16%	4.18%	5.64%	6.56%
Return On Investment Capital (ROIC_SIMPLE)	2.46%	3.96%	1.10%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	2.49%	1.72%	2.69%	0.00%	1.05%	1.77%	1.89%	2.06%	2.44%	0.00%
SG&A Expenses to Revenue	12.62%	10.98%	10.75%	13.97%	9.14%	9.28%	8.00%	8.36%	8.88%	10.35%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	61.95%	58.14%	84.11%	44.60%	40.32%	53.73%	44.76%	62.95%	47.42%	55.24%
Earnings before Interest and Taxes (EBIT)	88	75	14	106	105	74	86	47	52	33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	145	129	66	164	159	128	134	88	86	59
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.59	1.80	1.92	2.11	1.93	1.67	1.52	1.54	1.35	1.32
Price to Tangible Book Value (P/TBV)	1.59	1.80	1.92	2.11	1.93	1.67	1.52	1.54	1.35	1.32
Price to Revenue (P/Rev)	20.23	12.84	8.70	10.03	9.89	9.48	7.45	6.87	5.85	4.67
Price to Earnings (P/E)	37.08	47.47	0.00	26.81	21.82	33.42	20.19	35.29	20.85	34.40
Dividend Yield	4.29%	5.23%	6.54%	5.33%	5.43%	5.55%	5.88%	6.15%	6.45%	8.93%
Earnings Yield	2.70%	2.11%	0.00%	3.73%	4.58%	2.99%	4.95%	2.83%	4.80%	2.91%
Enterprise Value to Invested Capital (EV/IC)	1.71	1.70	1.53	1.65	1.60	1.44	1.31	1.27	1.17	1.12
Enterprise Value to Revenue (EV/Rev)	17.65	13.46	11.64	13.35	12.76	12.55	10.22	10.88	9.94	9.72
Enterprise Value to EBITDA (EV/EBITDA)	27.86	20.77	32.89	15.66	14.29	15.97	12.02	16.48	12.04	12.10
Enterprise Value to EBIT (EV/EBIT)	45.80	35.44	157.26	24.12	21.77	27.52	18.70	31.10	19.92	21.72
Enterprise Value to NOPAT (EV/NOPAT)	49.64	33.54	125.97	24.10	21.77	28.20	19.16	31.10	19.82	21.72
Enterprise Value to Operating Cash Flow (EV/OCF)	16.57	17.27	15.11	16.37	15.62	16.23	16.15	16.30	16.15	17.87
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	15.10	0.00	21.20	0.00	292.25	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.14	0.42	0.85	0.74	0.60	0.60	0.64	0.94	0.99	1.50
Long-Term Debt to Equity	0.14	0.42	0.85	0.74	0.60	0.60	0.64	0.94	0.99	1.50
Financial Leverage	-0.09	0.32	0.69	0.63	0.55	0.56	0.73	0.94	1.15	1.87
Leverage Ratio	1.27	1.63	1.85	1.72	1.64	1.66	1.82	2.02	2.24	3.06
Compound Leverage Factor	1.79	1.16	-1.00	1.16	1.27	1.03	1.23	1.12	1.26	0.93
Debt to Total Capital	11.93%	29.57%	45.86%	42.37%	37.38%	37.42%	38.93%	48.45%	49.85%	60.03%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	11.93%	29.57%	45.86%	42.37%	37.38%	37.42%	38.93%	48.45%	49.85%	60.03%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.63%	0.09%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	87.44%	70.34%	54.14%	57.63%	62.62%	62.58%	61.07%	51.55%	50.15%	39.97%
Debt to EBITDA	2.73	4.63	10.84	4.11	3.43	4.32	3.67	6.37	5.20	6.63
Net Debt to EBITDA	-4.21	0.94	8.29	3.89	3.21	3.90	3.26	6.08	4.96	6.29
Long-Term Debt to EBITDA	2.73	4.63	10.84	4.11	3.43	4.32	3.67	6.37	5.20	6.63
Debt to NOPAT	4.87	7.47	41.53	6.32	5.22	7.63	5.85	12.01	8.57	11.89
Net Debt to NOPAT	-7.51	1.52	31.75	5.99	4.89	6.89	5.19	11.48	8.16	11.29
Long-Term Debt to NOPAT	4.87	7.47	41.53	6.32	5.22	7.63	5.85	12.01	8.57	11.89
Altman Z-Score	5.72	2.65	1.39	1.93	2.15	1.86	1.70	1.15	1.06	0.77
Noncontrolling Interest Sharing Ratio	0.53%	0.08%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.13	4.51	0.49	1.17	1.59	2.26	1.68	0.42	0.64	0.94
Quick Ratio	2.81	4.18	0.26	0.88	1.06	1.53	1.43	0.39	0.58	0.81
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-714	-69	145	-22	107	-135	5.49	-204	-195	-176
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	0.00%	8,628.48%	4,526.70%	0.00%	22,034.74%	23.13%	17.30%
Free Cash Flow to Firm to Interest Expense	-23.06	-1.70	4.82	-0.63	4.54	-4.80	0.20	-8.44	-8.54	-7.30
Operating Cash Flow to Interest Expense	7.89	3.79	4.81	4.55	6.16	4.49	3.57	3.67	2.82	1.67
Operating Cash Flow Less CapEx to Interest Expense	8.08	3.92	6.07	4.57	6.09	4.39	3.71	3.65	-9.36	-8.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.08	0.11	0.12	0.12	0.12	0.12	0.13	0.13	0.13	0.13
Accounts Receivable Turnover	292.25	489.76	132.33	90.71	81.17	23.41	18.86	23.85	25.41	31.94
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.12	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.13	0.12	0.20	0.00	0.11	0.19	0.18	0.19	0.24	0.00
Days Sales Outstanding (DSO)	1.25	0.75	2.76	4.02	4.50	15.59	19.35	15.30	14.36	11.43
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	2,884.42	3,111.08	1,802.47	0.00	3,372.10	1,947.74	2,055.28	1,973.24	1,532.60	0.00
Cash Conversion Cycle (CCC)	-2,883.17	-3,110.34	-1,799.71	4.02	-3,367.60	-1,932.15	-2,035.93	-1,957.94	-1,518.24	11.43
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,372	1,576	1,427	1,554	1,426	1,429	1,221	1,143	892	644
Invested Capital Turnover	0.12	0.13	0.13	0.13	0.13	0.12	0.13	0.13	0.14	0.14
Increase / (Decrease) in Invested Capital	796	149	-127	128	-2.77	208	78	251	248	209
Enterprise Value (EV)	4,047	2,674	2,182	2,568	2,276	2,050	1,604	1,447	1,040	719
Market Capitalization	4,638	2,551	1,632	1,930	1,764	1,549	1,169	913	612	345
Book Value per Share	$16.96	$11.89	$8.75	$9.44	$9.55	$9.71	$9.16	$7.83	$7.79	$5.45
Tangible Book Value per Share	$16.96	$11.89	$8.75	$9.44	$9.55	$9.71	$9.16	$7.83	$7.79	$5.45
Total Capital	3,326	2,014	1,569	1,589	1,460	1,482	1,258	1,154	902	656
Total Debt	397	596	719	673	546	555	490	559	450	394
Total Long-Term Debt	397	596	719	673	546	555	490	559	450	394
Net Debt	-612	121	550	638	512	501	435	534	428	374
Capital Expenditures (CapEx)	-5.89	-5.34	-38	-0.95	1.69	2.79	-3.99	0.40	279	233
Debt-free, Cash-free Net Working Capital (DFCFNWC)	22	-47	-40	-15	-7.30	-1.54	-14	-25	-16	-13
Debt-free Net Working Capital (DFNWC)	236	248	-27	4.42	12	19	23	-18	-8.45	-1.08
Net Working Capital (NWC)	236	248	-27	4.42	12	19	23	-18	-8.45	-1.08
Net Nonoperating Expense (NNE)	-43	26	25	35	24	26	26	21	23	23
Net Nonoperating Obligations (NNO)	-558	157	578	638	512	501	453	548	439	382
Total Depreciation and Amortization (D&A)	57	53	52	57	55	54	48	41	34	26
Debt-free, Cash-free Net Working Capital to Revenue	9.63%	-23.56%	-21.23%	-8.05%	-4.09%	-0.94%	-8.73%	-19.03%	-15.23%	-16.96%
Debt-free Net Working Capital to Revenue	102.89%	124.70%	-14.20%	2.30%	6.52%	11.50%	14.72%	-13.84%	-8.07%	-1.46%
Net Working Capital to Revenue	102.89%	124.70%	-14.20%	2.30%	6.52%	11.50%	14.72%	-13.84%	-8.07%	-1.46%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.81	$0.50	($0.08)	$0.74	$0.85	$0.49	$0.73	$0.35	$0.52	$0.26
Adjusted Weighted Average Basic Shares Outstanding	154.80M	105.96M	96.70M	96.02M	95.20M	93.09M	79.39M	72.65M	56.03M	37.38M
Adjusted Diluted Earnings per Share	$0.80	$0.50	($0.08)	$0.74	$0.85	$0.49	$0.72	$0.35	$0.52	$0.26
Adjusted Weighted Average Diluted Shares Outstanding	155.17M	106.15M	96.70M	96.09M	95.21M	93.10M	79.39M	72.65M	56.03M	37.38M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	187.66M	130.50M	99.51M	97.05M	95.89M	95.47M	88.85M	76.14M	66.22M	48.15M
Normalized Net Operating Profit after Tax (NOPAT)	87	81	73	75	73	63	59	33	37	23
Normalized NOPAT Margin	37.78%	40.89%	38.75%	38.78%	41.04%	38.30%	37.35%	24.96%	35.24%	31.33%
Pre Tax Income Margin	54.26%	27.05%	-4.00%	37.42%	45.35%	28.37%	36.91%	19.46%	28.04%	13.56%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.85	1.85	0.46	3.09	4.42	2.65	3.08	1.92	2.28	1.38
NOPAT to Interest Expense	2.63	1.95	0.58	3.09	4.42	2.59	3.01	1.92	2.29	1.38
EBIT Less CapEx to Interest Expense	3.04	1.98	1.72	3.11	4.35	2.55	3.22	1.91	-9.89	-8.30
NOPAT Less CapEx to Interest Expense	2.82	2.08	1.84	3.12	4.35	2.49	3.15	1.91	-9.88	-8.30
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	138.45%	215.06%	-1,414.04%	140.01%	115.20%	173.90%	108.76%	203.24%	126.97%	217.16%
Augmented Payout Ratio	138.45%	215.06%	-1,414.04%	140.01%	115.20%	173.90%	108.76%	203.24%	126.97%	217.16%

This table displays calculated financial ratios and metrics derived from CareTrust REIT's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	39.16%	-50.87%	38.48%	33.63%	24.63%	-6.07%	11.10%	8.41%	8.89%	-14.05%	3.47%
EBITDA Growth	67.40%	-80.30%	61.06%	42.98%	20.43%	3.60%	56.00%	-40.36%	279.06%	-28.70%	-49.10%
EBIT Growth	84.54%	-164.59%	106.58%	80.91%	27.27%	0.18%	125.45%	-60.86%	177.43%	-37.18%	-68.13%
NOPAT Growth	62.15%	-243.33%	66.24%	180.30%	27.05%	-29.18%	59.97%	-72.29%	212.06%	-20.19%	-43.53%
Net Income Growth	126.76%	97.59%	283.14%	2,252.48%	49.53%	82.85%	1,124.96%	-102.34%	144.44%	-21.25%	-94.05%
EPS Growth	59.09%	25.00%	162.50%	800.00%	15.79%	60.00%	700.00%	-104.76%	142.22%	-21.05%	-91.67%
Operating Cash Flow Growth	46.21%	76.25%	49.08%	66.24%	39.01%	26.46%	6.47%	-5.51%	1.56%	-12.37%	-11.37%
Free Cash Flow Firm Growth	-568.60%	-502.20%	-102.93%	-649.80%	-221.10%	-192.32%	-162.86%	-106.06%	1,811.53%	241.09%	189.48%
Invested Capital Growth	84.64%	50.48%	12.82%	11.95%	16.23%	10.45%	7.09%	1.93%	-8.32%	-8.19%	-6.85%
Revenue Q/Q Growth	273.61%	-74.25%	12.32%	9.23%	5.58%	-27.41%	8.39%	1.87%	-2.32%	-14.14%	5.76%
EBITDA Q/Q Growth	1,105.28%	-89.65%	60.72%	-32.32%	5.14%	-15.40%	42.67%	-42.99%	14.95%	27.38%	-45.45%
EBIT Q/Q Growth	608.92%	-123.54%	121.05%	-48.36%	7.00%	-24.69%	93.59%	-63.67%	21.12%	69.48%	-66.39%
NOPAT Q/Q Growth	330.33%	-146.18%	103.79%	-44.24%	14.12%	-46.44%	243.61%	-74.73%	5.44%	20.98%	-40.47%
Net Income Q/Q Growth	25.48%	56.13%	219.41%	-63.76%	9.34%	202.75%	1,894.42%	-102.52%	33.71%	1,928.21%	-96.57%
EPS Q/Q Growth	16.67%	42.86%	200.00%	-68.18%	-8.33%	200.00%	900.00%	-105.26%	26.67%	1,400.00%	-95.24%
Operating Cash Flow Q/Q Growth	-5.09%	11.84%	26.94%	8.51%	14.41%	-5.41%	41.56%	-9.27%	4.08%	-20.36%	25.64%
Free Cash Flow Firm Q/Q Growth	-63.49%	-420.73%	4.57%	13.56%	-63.31%	-75.48%	-252.61%	-113.96%	0.94%	19.48%	-66.00%
Invested Capital Q/Q Growth	26.79%	35.27%	1.17%	6.41%	3.34%	1.41%	0.39%	10.47%	-1.80%	-1.68%	-4.44%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	99.86%	93.37%	95.51%	99.63%	98.95%	98.61%	97.78%	98.72%	98.10%	98.39%	92.43%
EBITDA Margin	91.98%	28.51%	70.96%	49.59%	80.04%	71.10%	61.01%	46.35%	82.83%	64.46%	43.45%
Operating Margin	61.00%	-98.95%	55.18%	30.41%	59.58%	33.92%	45.97%	20.71%	58.45%	44.98%	31.93%
EBIT Margin	67.94%	-49.87%	54.55%	27.72%	58.63%	37.94%	36.57%	20.48%	57.41%	35.57%	18.02%
Profit (Net Income) Margin	87.56%	260.71%	43.00%	15.12%	45.58%	64.82%	15.54%	-0.94%	37.99%	33.30%	1.41%
Tax Burden Percent	98.66%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	130.64%	-522.74%	78.83%	54.55%	77.75%	170.86%	42.50%	-4.59%	66.18%	93.61%	7.82%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	6.59%	-11.49%	8.98%	4.59%	9.06%	4.49%	6.42%	1.93%	7.99%	5.66%	4.13%
ROIC Less NNEP Spread (ROIC-NNEP)	352.32%	-47.30%	17.23%	0.55%	5.62%	7.90%	3.27%	0.81%	6.33%	4.83%	1.73%
Return on Net Nonoperating Assets (RNNOA)	0.87%	4.36%	-1.11%	0.11%	1.15%	2.56%	1.84%	0.69%	4.67%	3.33%	1.27%
Return on Equity (ROE)	7.46%	-7.14%	7.87%	4.70%	10.20%	7.05%	8.26%	2.62%	12.67%	8.99%	5.40%
Cash Return on Invested Capital (CROIC)	-55.20%	-36.18%	-3.94%	-4.14%	-7.95%	-4.63%	-0.59%	3.59%	15.55%	9.70%	8.47%
Operating Return on Assets (OROA)	5.45%	-4.14%	6.26%	3.09%	6.80%	4.07%	4.50%	2.44%	7.15%	4.09%	2.13%
Return on Assets (ROA)	7.03%	21.65%	4.94%	1.69%	5.29%	6.95%	1.91%	-0.11%	4.73%	3.83%	0.17%
Return on Common Equity (ROCE)	7.42%	-7.10%	7.86%	4.69%	10.19%	7.04%	8.25%	2.62%	12.66%	8.99%	5.40%
Return on Equity Simple (ROE_SIMPLE)	5.49%	0.00%	4.08%	3.81%	3.78%	0.00%	3.77%	4.16%	6.54%	0.00%	-0.45%
Net Operating Profit after Tax (NOPAT)	45	-20	43	21	38	14	26	7.48	30	19	16
NOPAT Margin	61.00%	-98.95%	55.18%	30.41%	59.58%	33.92%	45.97%	14.50%	58.45%	44.98%	31.93%
Net Nonoperating Expense Percent (NNEP)	-345.73%	35.80%	-8.25%	4.04%	3.44%	-3.41%	3.15%	1.12%	1.66%	0.83%	2.40%
Return On Investment Capital (ROIC_SIMPLE)	1.21%	-0.60%	-	-	-	0.68%	-	-	-	1.24%	-
Cost of Revenue to Revenue	0.14%	6.63%	4.49%	0.37%	1.05%	1.39%	2.22%	1.28%	1.90%	1.61%	7.57%
SG&A Expenses to Revenue	12.12%	46.60%	8.61%	8.91%	10.84%	16.04%	9.88%	9.15%	10.00%	11.15%	10.26%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	38.86%	192.32%	40.33%	69.22%	39.37%	64.69%	51.81%	78.01%	39.65%	53.41%	60.50%
Earnings before Interest and Taxes (EBIT)	51	-9.94	42	19	37	15	20	11	29	15	9.06
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	68	5.68	55	34	50	29	34	24	42	28	22
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.83	1.59	1.96	1.83	1.71	1.80	1.76	2.31	2.17	1.92	1.97
Price to Tangible Book Value (P/TBV)	1.83	1.59	1.96	1.83	1.71	1.80	1.76	2.31	2.17	1.92	1.97
Price to Revenue (P/Rev)	21.43	20.23	17.69	14.40	12.46	12.84	9.29	9.20	9.12	8.70	8.22
Price to Earnings (P/E)	33.08	37.08	47.95	47.87	45.36	47.47	46.59	55.54	33.23	0.00	0.00
Dividend Yield	4.22%	4.29%	3.73%	4.54%	4.69%	5.23%	5.69%	5.88%	6.02%	6.54%	6.61%
Earnings Yield	3.02%	2.70%	2.09%	2.09%	2.20%	2.11%	2.15%	1.80%	3.01%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.79	1.71	2.30	1.91	1.71	1.70	1.52	1.67	1.70	1.53	1.52
Enterprise Value to Revenue (EV/Rev)	21.50	17.65	15.02	13.37	12.09	13.46	11.25	12.66	11.92	11.64	11.36
Enterprise Value to EBITDA (EV/EBITDA)	31.13	27.86	21.54	19.85	17.78	20.77	17.31	20.84	17.02	32.89	28.50
Enterprise Value to EBIT (EV/EBIT)	48.24	45.80	30.41	29.80	27.14	35.44	28.09	35.59	26.81	157.26	96.23
Enterprise Value to NOPAT (EV/NOPAT)	54.39	49.64	30.12	28.26	26.04	33.54	25.11	30.66	23.72	125.97	106.46
Enterprise Value to Operating Cash Flow (EV/OCF)	20.16	16.57	19.08	17.46	16.52	17.27	16.18	18.07	16.47	15.11	14.82
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	47.02	10.48	15.10	17.34
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.28	0.14	0.16	0.34	0.36	0.42	0.54	1.08	0.87	0.85	0.95
Long-Term Debt to Equity	0.28	0.14	0.16	0.34	0.36	0.42	0.54	0.73	0.87	0.85	0.95
Financial Leverage	0.00	-0.09	-0.06	0.19	0.20	0.32	0.56	0.86	0.74	0.69	0.74
Leverage Ratio	1.35	1.27	1.33	1.61	1.58	1.63	1.77	2.07	1.91	1.85	1.90
Compound Leverage Factor	1.76	-6.64	1.05	0.88	1.23	2.79	0.75	-0.10	1.26	1.73	0.15
Debt to Total Capital	21.81%	11.93%	14.06%	25.65%	26.23%	29.57%	34.89%	51.84%	46.48%	45.86%	48.76%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	16.59%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	21.81%	11.93%	14.06%	25.65%	26.23%	29.57%	34.89%	35.25%	46.48%	45.86%	48.76%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.55%	0.63%	0.09%	0.08%	0.10%	0.09%	0.06%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	77.64%	87.44%	85.85%	74.27%	73.67%	70.34%	65.05%	48.16%	53.52%	54.14%	51.18%
Debt to EBITDA	4.76	2.73	2.12	4.02	3.81	4.63	4.37	7.05	5.20	10.84	9.98
Net Debt to EBITDA	-0.02	-4.21	-3.84	-1.54	-0.57	0.94	3.01	5.70	4.00	8.29	7.87
Long-Term Debt to EBITDA	4.76	2.73	2.12	4.02	3.81	4.63	4.37	4.79	5.20	10.84	9.98
Debt to NOPAT	8.31	4.87	2.96	5.73	5.58	7.47	6.33	10.37	7.25	41.53	37.29
Net Debt to NOPAT	-0.04	-7.51	-5.38	-2.20	-0.83	1.52	4.37	8.38	5.57	31.75	29.41
Long-Term Debt to NOPAT	8.31	4.87	2.96	5.73	5.58	7.47	6.33	7.05	7.25	41.53	37.29
Altman Z-Score	3.57	5.62	6.02	3.15	2.92	2.56	1.91	1.14	1.61	1.40	1.27
Noncontrolling Interest Sharing Ratio	0.50%	0.53%	0.10%	0.08%	0.09%	0.08%	0.11%	0.06%	0.06%	0.00%	0.06%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.74	3.13	4.14	6.44	6.27	4.51	0.40	0.05	2.40	0.49	0.43
Quick Ratio	1.10	2.81	3.80	6.06	5.91	4.18	0.06	0.00	1.18	0.26	0.10
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,333	-815	-157	-164	-190	-135	-77	-22	157	147	123
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	6,374.85%	13,869.32%	0.00%	1,635.01%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	-199.88	-159.19	-17.52	-18.91	-23.07	-16.38	-6.57	-1.98	15.95	15.26	14.69
Operating Cash Flow to Interest Expense	10.70	14.68	7.52	6.10	5.93	5.16	3.84	2.89	3.57	3.51	5.07
Operating Cash Flow Less CapEx to Interest Expense	17.02	15.66	7.75	6.01	5.89	5.16	3.60	3.51	3.70	4.47	8.82
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.08	0.08	0.11	0.11	0.12	0.11	0.12	0.12	0.12	0.12	0.12
Accounts Receivable Turnover	212.41	292.25	425.75	333.88	546.23	489.76	352.39	323.71	258.24	132.33	90.88
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.13	0.12	0.16	0.15	0.00	0.13	0.14	0.14	0.00	0.00	0.00
Accounts Payable Turnover	0.12	0.13	0.13	0.09	0.11	0.12	0.12	0.29	0.23	0.20	0.15
Days Sales Outstanding (DSO)	1.72	1.25	0.86	1.09	0.67	0.75	1.04	1.13	1.41	2.76	4.02
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	3,054.43	2,884.42	2,893.89	3,905.98	3,476.86	3,111.08	3,065.02	1,275.12	1,575.32	1,802.47	2,419.51
Cash Conversion Cycle (CCC)	-3,052.71	-2,883.17	-2,893.03	-3,904.89	-3,476.19	-3,110.34	-3,063.99	-1,273.99	-1,573.90	-1,799.71	-2,415.49
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,007	2,372	1,753	1,733	1,629	1,576	1,554	1,548	1,401	1,427	1,451
Invested Capital Turnover	0.11	0.12	0.16	0.15	0.15	0.13	0.14	0.13	0.14	0.13	0.13
Increase / (Decrease) in Invested Capital	1,378	796	199	185	227	149	103	29	-127	-127	-107
Enterprise Value (EV)	5,380	4,047	4,040	3,310	2,783	2,674	2,360	2,586	2,388	2,182	2,210
Market Capitalization	5,363	4,638	4,759	3,566	2,869	2,551	1,948	1,879	1,827	1,632	1,600
Book Value per Share	$15.60	$16.96	$15.71	$13.68	$12.60	$11.89	$11.16	$8.17	$8.44	$8.75	$8.38
Tangible Book Value per Share	$15.60	$16.96	$15.71	$13.68	$12.60	$11.89	$11.16	$8.17	$8.44	$8.75	$8.38
Total Capital	3,770	3,326	2,821	2,617	2,272	2,014	1,706	1,688	1,570	1,569	1,588
Total Debt	822	397	397	671	596	596	595	875	730	719	774
Total Long-Term Debt	822	397	397	671	596	596	595	595	730	719	774
Net Debt	-4.16	-612	-721	-258	-89	121	411	707	561	550	611
Capital Expenditures (CapEx)	-42	-5.01	-2.06	0.83	0.35	-0.01	2.76	-6.87	-1.21	-9.22	-31
Debt-free, Cash-free Net Working Capital (DFCFNWC)	58	22	-65	-50	-48	-47	-40	-34	5.79	-40	-38
Debt-free Net Working Capital (DFNWC)	85	236	312	445	403	248	-37	-33	34	-27	-33
Net Working Capital (NWC)	85	236	312	445	403	248	-37	-313	34	-27	-33
Net Nonoperating Expense (NNE)	-20	-72	9.42	11	8.83	-13	17	7.96	10	5.05	15
Net Nonoperating Obligations (NNO)	59	-558	-671	-213	-47	157	443	735	561	578	638
Total Depreciation and Amortization (D&A)	18	16	13	15	14	13	14	13	13	12	13
Debt-free, Cash-free Net Working Capital to Revenue	23.32%	9.63%	-24.06%	-20.29%	-20.99%	-23.56%	-19.15%	-16.87%	2.89%	-21.23%	-19.44%
Debt-free Net Working Capital to Revenue	33.91%	102.89%	116.09%	179.70%	174.98%	124.70%	-17.49%	-16.31%	16.91%	-14.20%	-16.94%
Net Working Capital to Revenue	33.91%	102.89%	116.09%	179.70%	174.98%	124.70%	-17.49%	-153.39%	16.91%	-14.20%	-16.94%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.35	$0.31	$0.21	$0.07	$0.22	$0.24	$0.08	($0.01)	$0.19	$0.15	$0.01
Adjusted Weighted Average Basic Shares Outstanding	187.15M	154.80M	159.46M	144.90M	132.84M	105.96M	104.01M	99.12M	99.06M	96.70M	96.61M
Adjusted Diluted Earnings per Share	$0.35	$0.30	$0.21	$0.07	$0.22	$0.24	$0.08	($0.01)	$0.19	$0.15	$0.01
Adjusted Weighted Average Diluted Shares Outstanding	187.42M	155.17M	159.85M	145.26M	133.20M	106.15M	104.31M	99.12M	99.09M	96.70M	96.63M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	191.69M	187.66M	171.45M	154.21M	142.06M	130.50M	119.11M	99.48M	99.48M	99.51M	97.03M
Normalized Net Operating Profit after Tax (NOPAT)	32	-10	36	33	28	13	24	22	22	17	20
Normalized NOPAT Margin	42.70%	-50.46%	46.24%	47.42%	44.75%	32.01%	42.49%	43.55%	43.52%	40.17%	39.50%
Pre Tax Income Margin	88.76%	260.71%	43.00%	15.12%	45.58%	64.82%	15.54%	-0.94%	37.99%	33.30%	1.41%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7.58	-1.94	4.72	2.20	4.49	1.86	1.74	0.96	2.96	1.60	1.08
NOPAT to Interest Expense	6.81	-3.85	4.78	2.41	4.57	1.66	2.19	0.68	3.01	2.02	1.92
EBIT Less CapEx to Interest Expense	13.90	-0.96	4.95	2.10	4.45	1.86	1.50	1.58	3.08	2.56	4.83
NOPAT Less CapEx to Interest Expense	13.13	-2.87	5.01	2.32	4.52	1.67	1.95	1.30	3.13	2.98	5.67
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	118.72%	138.45%	156.93%	186.20%	197.17%	215.06%	262.51%	320.90%	195.51%	-1,414.04%	-2,899.64%
Augmented Payout Ratio	118.72%	138.45%	156.93%	186.20%	197.17%	215.06%	262.51%	320.90%	195.51%	-1,414.04%	-2,899.64%

Frequently Asked Questions About CareTrust REIT's Financials

When does CareTrust REIT's financial year end?

According to the most recent income statement we have on file, CareTrust REIT's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has CareTrust REIT's net income changed over the last 9 years?

CareTrust REIT's net income appears to be on an upward trend, with a most recent value of $124.40 million in 2024, rising from $10.03 million in 2015. The previous period was $53.72 million in 2023. See CareTrust REIT's forecast for analyst expectations on what’s next for the company.

What is CareTrust REIT's operating income?

CareTrust REIT's total operating income in 2024 was $81.51 million, based on the following breakdown:

Total Gross Profit: $223.56 million
Total Operating Expenses: $142.04 million

How has CareTrust REIT revenue changed over the last 9 years?

Over the last 9 years, CareTrust REIT's total revenue changed from $73.99 million in 2015 to $229.27 million in 2024, a change of 209.9%.

How much debt does CareTrust REIT have?

CareTrust REIT's total liabilities were at $507.63 million at the end of 2024, a 23.8% decrease from 2023, and a 23.5% increase since 2015.

How much cash does CareTrust REIT have?

In the past 9 years, CareTrust REIT's cash and equivalents has ranged from $6.91 million in 2017 to $294.45 million in 2023, and is currently $213.82 million as of their latest financial filing in 2024.

How has CareTrust REIT's book value per share changed over the last 9 years?

Over the last 9 years, CareTrust REIT's book value per share changed from 5.45 in 2015 to 16.96 in 2024, a change of 211.4%.

Related Companies

This page (NASDAQ:CTRE) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CareTrust REIT (CTRE) Financials

Frequently Asked Questions About CareTrust REIT's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CareTrust REIT (CTRE) Financials

Annual Income Statements for CareTrust REIT

Quarterly Income Statements for CareTrust REIT

Annual Cash Flow Statements for CareTrust REIT

Quarterly Cash Flow Statements for CareTrust REIT

Annual Balance Sheets for CareTrust REIT

Quarterly Balance Sheets for CareTrust REIT

Annual Metrics And Ratios for CareTrust REIT

Quarterly Metrics And Ratios for CareTrust REIT

Frequently Asked Questions About CareTrust REIT's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools